{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1452","meta":{"versionId":"8","lastUpdated":"2018-03-14T01:00:05.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2018-03-14"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1452","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.196.11.1452"}],"version":"20180314","name":"BrompheniramineHydrocodonePhenylephrine","title":"Brompheniramine / Hydrocodone / Phenylephrine","status":"active","experimental":false,"date":"2018-03-14T01:00:05-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"857716","display":"Brompheniramine 1.2 MG/ML / Hydrocodone Bitartrate 1 MG/ML / Phenylephrine 2 MG/ML Extended Release Suspension"}]}]},"expansion":{"identifier":"urn:uuid:be7cbf35-6b13-4b75-8d98-69ca46bef345","timestamp":"2023-12-11T02:33:22-05:00","total":0}}